Short Stature Management Guide

A sequential approach for pediatricians.

pediapp.online© 2026.

Step 1: Initial Evaluation and History

Key Points to Investigate

  • Anamnesis: Perinatal history (birth weight/length, gestational age), chronic diseases, use of medications (corticosteroids), sleep pattern and nutrition.
  • Family History: Parental height, age of maternal and paternal puberty (familial delayed puberty).
  • Complete Physical Examination: Search for dysmorphisms, phenotype of known syndromes (Turner, Noonan), nutritional status and body proportions.
  • Precise Anthropometry: Measure and graph height, weight and BMI on the corresponding growth curves (WHO or local). Calculate growth speed (cm/year).

Essential Calculations

Diana Size (Family White)

Children: [(Father size + Mother size + 13) / 2] ± 8.5 cm

Girls: [(Father size + Mother size - 13) / 2] ± 8.5 cm

Growth Speed

Minimum two measurements separated by 4-6 months. A VC < 25th percentile for age is a warning sign.

Initial Studies to Consider

They are requested if the size is < -2 SD (or P3), the VC is low, or there are alarm data.

  • Complete blood count and ESR: Rule out anemia, inflammatory processes.
  • Blood chemistry: Kidney (Urea, Creatinine) and liver function.
  • Serum electrolytes, venous blood gases: Rule out renal tubular acidosis.
  • Thyroid profile: TSH and Free T4 (treatable and frequent cause of hypogrowth).
  • Bone age (left carpal X-ray): Fundamental to assess skeletal maturation. A delay >2 years with respect to chronological age is significant.

Step 2: Reevaluation and Initial Management

Monitoring and Criteria

Reevaluate in 3 to 6 months to confirm the growth rate. Compare laboratory results with reference values ​​for age.

If the bone age is very delayed or there is hypothyroidism, start specific treatment (levothyroxine) and reevaluate. Hypothyroidism must be corrected before any other hormonal study.

Initial Therapeutic Options (If deficiency is detected)

These interventions are based on nutritional optimization and only if a specific deficiency is proven. They are not "growth stimulants" per se.

Zinc Deficiency

Presentation: Zinc sulfate in solution or tablets.

Dose: 1-2 mg/kg/day of elemental zinc for 3-6 months.

Iron Deficiency (Iron Deficiency Anemia)

Presentation: Ferrous sulfate in drops or syrup.

Therapeutic Dosage: 3-6 mg/kg/day of elemental iron, divided into 1-2 doses.

Vitamin D supplementation should be considered according to local guidelines for the general population.

Step 3: Referral Criteria to Specialists

When to refer to the Pediatric Endocrinologist?

  • Size consistently < -2.5 SD for age and sex.
  • Height below genetic potential (e.g. > 2 SD below target height).
  • Persistently low growth rate (< P25) despite optimizing nutrition and general health.
  • Fall of more than 1 OF in the growth curves.
  • Bone age with a delay > 2 years compared to chronological age (without hypothyroidism).
  • Signs suggestive of Growth Hormone deficiency (hypoglycemia, micropenis).
  • Dysmorphisms or stigmata of genetic syndromes (Turner, Noonan, etc.).

When to refer to other specialties?

Gastroenterology

Suspected celiac disease, inflammatory bowel disease, malabsorption (chronic diarrhea, abdominal pain, weight more affected than height).

Nephrology

Alterations in EGO, elevated urea/creatinine, metabolic acidosis, arterial hypertension.

Genetics

Facial dysmorphisms, congenital malformations, suspicion of specific syndromes, marked body disproportion.

Cardiology

Heart murmur, weak femoral pulses (suggestive of aortic coarctation, associated with Turner Syndrome).

Step 4: Management by Pediatric Endocrinology

Advanced Diagnostic Tests

  • IGF-1 (Insulin-like Growth Factor type 1) and IGFBP-3: They are markers of the action of growth hormone (GH). Low values ​​suggest GH deficiency, but may be normal.
  • GH stimulation tests: Gold standard for the diagnosis of GH deficiency. Pharmacological stimuli (clonidine, arginine, insulin) are used to measure the maximal GH response. A low peak confirms the diagnosis.
  • Karyotype: MANDATORY in all girls with short stature of unknown cause to rule out Turner Syndrome.
  • Specific genetic tests: Short panels, exome, if there is high suspicion of a genetic cause.

Therapeutic Options (Specialized Management)

Human Recombinant Growth Hormone (GH)

Indicated in confirmed cases of:

  • Growth Hormone Deficiency (GHD).
  • Turner syndrome.
  • Noonan syndrome.
  • Chronic Kidney Failure.
  • Small for Gestational Age (SGA) that does not regain growth.
  • Idiopathic short stature (in some countries and selected cases).

Presentation: Prefilled pen devices for daily subcutaneous injection.

Dose: It is highly individualized and is adjusted by weight. It varies depending on the indication. Example range for DGH: 0.025 - 0.035 mg/kg/day.

Recommendations for Parents

What YES to do

  • Ensure a balanced diet: Rich in proteins, calcium, vitamins and minerals. Limit sugars and ultra-processed foods.
  • Promote adequate sleep: Peak growth hormone secretion occurs during deep sleep. Ensure sufficient hours of sleep for your age.
  • Encourage regular physical activity: Exercise stimulates the musculoskeletal system and general well-being.
  • Maintain an emotionally healthy environment: Chronic stress can negatively affect growth.
  • Follow the pediatrician's instructions: Go to the controls and carry out the indicated studies.

What NOT to do

  • Don't compare the child with his siblings, cousins ​​or classmates. Each child has their own growth rate.
  • Do not administer "miracle" supplements or vitamins without medical indication. They may be ineffective or even harmful.
  • Do not subject the child to restrictive diets without professional supervision, since they can limit the caloric intake and essential nutrients for growth.
  • Do not generate anxiety in the child because of his height. Short stature does not define your value or your capabilities.
  • Don't pressure the doctor to use growth hormone if not indicated. It is a treatment with precise indications and requires specialized supervision.

Knowledge Assessment

1. What is the most important INITIAL imaging study to evaluate maturation in a child with short stature?

2. In EVERY girl with short stature of unexplained cause, what study is mandatory to request?

3. Which of the following is an indication for referral to a pediatric endocrinologist?

4. Treatment with Growth Hormone (GH) is administered as follows:

5. What advice would you NOT give to parents of a child with constitutional short stature?

Recommended Bibliography
  • Graber, E. et al. (2022). Evaluation of short stature in children. In UpToDate. Retrieved from UpToDate Online.
  • Richmond, E., & Rogol, A. D. (2016). Causes of short stature. Pediatric Clinics, 63(3), 485-502.
  • Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. 2000;85(11):3990-3.
  • Argente, J., et al. (2017). Low size. In: Treatise on Pediatric Endocrinology and Adolescence. 2nd ed. McGraw-Hill.